Trial Profile
Double blind, randomized, placebo-controlled, two-way crossover, pilot study to assess the effect of high dose N acetylcysteine on small airways and on inflammation and oxidative stress in COPD patients
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 22 Sep 2014
Price :
$35
*
At a glance
- Drugs Acetylcysteine (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 22 Sep 2014 New trial record